207 related articles for article (PubMed ID: 19436302)
21. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia.
Real PJ; Tosello V; Palomero T; Castillo M; Hernando E; de Stanchina E; Sulis ML; Barnes K; Sawai C; Homminga I; Meijerink J; Aifantis I; Basso G; Cordon-Cardo C; Ai W; Ferrando A
Nat Med; 2009 Jan; 15(1):50-8. PubMed ID: 19098907
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoid receptor knock down reveals a similar apoptotic threshold but differing gene regulation patterns in T-cell and pre-B-cell acute lymphoblastic leukemia.
Schwartz JR; Sarvaiya PJ; Vedeckis WV
Mol Cell Endocrinol; 2010 May; 320(1-2):76-86. PubMed ID: 20170710
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia.
Serafin V; Capuzzo G; Milani G; Minuzzo SA; Pinazza M; Bortolozzi R; Bresolin S; Porcù E; Frasson C; Indraccolo S; Basso G; Accordi B
Blood; 2017 Dec; 130(25):2750-2761. PubMed ID: 29101238
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes.
Meyer LK; Huang BJ; Delgado-Martin C; Roy RP; Hechmer A; Wandler AM; Vincent TL; Fortina P; Olshen AB; Wood BL; Horton TM; Shannon KM; Teachey DT; Hermiston ML
J Clin Invest; 2020 Feb; 130(2):863-876. PubMed ID: 31687977
[TBL] [Abstract][Full Text] [Related]
25. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
[TBL] [Abstract][Full Text] [Related]
26. PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis.
Lim JT; Singh N; Leuvano LA; Calvert VS; Petricoin EF; Teachey DT; Lock RB; Padi M; Kraft AS; Padi SKR
Mol Cancer Ther; 2020 Sep; 19(9):1809-1821. PubMed ID: 32753387
[TBL] [Abstract][Full Text] [Related]
27. Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia.
Follini E; Marchesini M; Roti G
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31226848
[TBL] [Abstract][Full Text] [Related]
28. PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia.
Silveira AB; Laranjeira AB; Rodrigues GO; Leal PC; Cardoso BA; Barata JT; Yunes RA; Zanchin NI; Brandalise SR; Yunes JA
Oncotarget; 2015 May; 6(15):13105-18. PubMed ID: 25869207
[TBL] [Abstract][Full Text] [Related]
29. Targeting of active mTOR inhibits primary leukemia T cells and synergizes with cytotoxic drugs and signaling inhibitors.
Batista A; Barata JT; Raderschall E; Sallan SE; Carlesso N; Nadler LM; Cardoso AA
Exp Hematol; 2011 Apr; 39(4):457-472.e3. PubMed ID: 21277936
[TBL] [Abstract][Full Text] [Related]
30. Anisomycin induces apoptosis of glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells via activation of mitogen-activated protein kinases p38 and JNK.
Liu Y; Ge J; Li Q; Gu L; Guo X; Ma ZG; Zhu YP
Neoplasma; 2013; 60(1):101-10. PubMed ID: 23067223
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.
Hulleman E; Kazemier KM; Holleman A; VanderWeele DJ; Rudin CM; Broekhuis MJ; Evans WE; Pieters R; Den Boer ML
Blood; 2009 Feb; 113(9):2014-21. PubMed ID: 18978206
[TBL] [Abstract][Full Text] [Related]
32. A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines.
Gu L; Zhang G; Zhang Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):269. PubMed ID: 31221196
[TBL] [Abstract][Full Text] [Related]
33. Differential network analysis and protein-protein interaction study reveals active protein modules in glucocorticoid resistance for infant acute lymphoblastic leukemia.
Mousavian Z; Nowzari-Dalini A; Rahmatallah Y; Masoudi-Nejad A
Mol Med; 2019 Aug; 25(1):36. PubMed ID: 31370801
[TBL] [Abstract][Full Text] [Related]
34. Network-based expression analysis reveals key genes related to glucocorticoid resistance in infant acute lymphoblastic leukemia.
Mousavian Z; Nowzari-Dalini A; Stam RW; Rahmatallah Y; Masoudi-Nejad A
Cell Oncol (Dordr); 2017 Feb; 40(1):33-45. PubMed ID: 27798768
[TBL] [Abstract][Full Text] [Related]
35. Methylprednisolone potentiates tetrandrine pharmacodynamics against human T lymphoblastoid leukemia MOLT-4 cells via regulation of NF-κB activation and cell cycle transition.
Xu W; Chen S; Wang X; Wu H; Yamada H; Hirano T
Steroids; 2020 Nov; 163():108714. PubMed ID: 32818521
[TBL] [Abstract][Full Text] [Related]
36. Targeting critical kinases and anti-apoptotic molecules overcomes steroid resistance in MLL-rearranged leukaemia.
de Groot AP; Saito Y; Kawakami E; Hashimoto M; Aoki Y; Ono R; Ogahara I; Fujiki S; Kaneko A; Sato K; Kajita H; Watanabe T; Takagi M; Tomizawa D; Koh K; Eguchi M; Ishii E; Ohara O; Shultz LD; Mizutani S; Ishikawa F
EBioMedicine; 2021 Feb; 64():103235. PubMed ID: 33581643
[TBL] [Abstract][Full Text] [Related]
37. Targeting steroid resistance in T-cell acute lymphoblastic leukemia.
De Smedt R; Morscio J; Goossens S; Van Vlierberghe P
Blood Rev; 2019 Nov; 38():100591. PubMed ID: 31353059
[TBL] [Abstract][Full Text] [Related]
38. ENO2 Promotes Cell Proliferation, Glycolysis, and Glucocorticoid-Resistance in Acute Lymphoblastic Leukemia.
Liu CC; Wang H; Wang WD; Wang L; Liu WJ; Wang JH; Geng QR; Lu Y
Cell Physiol Biochem; 2018; 46(4):1525-1535. PubMed ID: 29689546
[TBL] [Abstract][Full Text] [Related]
39. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
Medh RD; Saeed MF; Johnson BH; Thompson EB
Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
[TBL] [Abstract][Full Text] [Related]
40. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
